33rd Annual Chemotherapy Foundation Symposium: Innovative Cancer Therapy for Tomorrow®

Credit Designation

Physicians' Education Resource®, LLC is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

This activity has been approved for AMA PRA Category 1 Credit™.

CONTINUING EDUCATION CREDIT (Pharmacists, Nurses, Nurse Practitioners, and Physician Assistants):
You will receive a certificate of attendance for the CME-certified sessions (those designated for AMA/PRA Category 1 Credits™) which may be submitted to state licensing boards for determination of credit reciprocity (conversion to CEUs).
33rd Annual Chemotherapy Foundation Symposium: Innovative Cancer Therapy for Tomorrow®

November 4 - 6, 2015
New York Marriott Marquis
1535 Broadway
New York, NY 10036


State-of-the-art cancer care continues to evolve due to advances in all aspects of patient care - including diagnosis, and personalized treatment and management. Through the incorporation of novel diagnostics, systemic therapies, molecular targeted therapies, immunotherapies, and other biotechnological strategies into treatment paradigms, patient outcomes continue to improve along the cancer continuum. The annual Chemotherapy Foundation Symposium: Innovative Cancer Therapy for Tomorrow® (CFS), has brought together over 2,000 oncologists, hematologists, radiotherapists, immunologists, oncology nurses, nurse practitioners, physician assistants, and case managers each year for 33 years, with the aim of educating these disciplines on state-of-the-art treatments across solid and hematologic malignancies and diverse clinical scenarios. At the 33rd Annual Chemotherapy Foundation Symposium: Innovative Cancer Therapy for Tomorrow® (CFS), renowned pioneers in virtually every tumor subspecialty will provide expert insights on new developments in cancer therapeutics, and provide oncology professionals with the opportunity to learn about new compounds, novel approaches to diagnosis and treatment with currently available agents, ongoing clinical trials, and emerging developments that define current progress aimed at the goal of control and cure of cancer.

Target Audience

This educational program is directed toward oncologists and hematologists interested in the treatment of patients with cancer. Radiotherapists, immunologists, fellows, nurse practitioners, nurses, physician assistants, researchers, case managers, and other health care professionals interested in the treatment of cancer are also invited to attend.

Program Co-Chairs

Edward Ambinder, MD
Clinical Professor
Medicine, Hematology and Medical Oncology
Clinical Professor
Oncological Sciences
Mt Sinai Hospital
New York, NY

Franco Muggia, MD
Department of Medicine
NYU Langone Medical Center
New York, NY

Calendar of Events
Filter By